Nice to see you are back on the forum, enthusiastic as ever. Was pleased to see closure on the litigation as a different outcome would have been crippling to the Company. I guess the legal costs will be high, but they can now put that behind them.
Wont surprise you that my current sentiment comes off the same hymn sheet as Qqqqqq. Unfortunately, in the case of MBE, the EBITDA number is not going to be a good indicator of NPAT. IMO, the financial results will not be pretty and I would not bet against negative NPAT for FY17.
We will however enter FY18 with a clearer picture of their 'new' core business, likely profitability and hopefully some confidence that they can rebuild eps.
I for one remain in 'wait & see' mode. No hurry to get back in IMO.
Rokewa
MBE Price at posting:
8.3¢ Sentiment: None Disclosure: Not Held